Windy City Media Group Frontpage News
Celebrating 30 Years of Gay Lesbian Bisexual and Trans News
home search facebook twitter join
Gay News Sponsor Windy City Times 2018-02-14
DOWNLOAD ISSUE
About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage

Sponsor
Sponsor

  WINDY CITY TIMES

Community Outraged at AIDS Drug Price Increase
by Bob Roehr
2003-12-31

facebook twitter del.icio.us stumble upon digg google +1 reddit email


Abbott Laboratories quietly increased the price of ritonavir (Norvir) by 400% Dec. 4, from $1.71 to $8.57 per 100 mg pill. The protease inhibitor (PI) primarily is used in sub-therapeutic doses with other protease inhibitors to delay their clearance by the liver. That means the price increase will be felt widely.

The AIDS community has only slowly become aware of the increase and is reacting with outrage and threats of boycott.

The company has asserted that the increase is a long-overdue price adjustment and reflects the cost of past research when they had to reformulate the compound. It also is not increasing the price to state-run AIDS drug assistance programs (ADAPs).

But many observers are calling it a ploy by Abbott to increase the market share of Kaletra, its other protease inhibitor. Kaletra had been losing ground to other PIs that have recently been approved for sale. This would boost the total cost of other PIs that must use Norvir as booster.

Michael Weinstein, president of the AIDS Healthcare Foundation, noted that even while the price of Norvir was skyrocketing, the price of Kaletra, which uses Norvir to boost its potency, did not increase at all.

'This is purely a marketing ploy to push for a larger market share for Kaletra by driving providers and patients to this cheaper Abbot combination therapy,' Weinstein said. 'The HIV community as a whole should unite and speak out against Abbott's bald-faced greed.'

'Abbott is feeding like a vulture on the bones of our healthcare system,' the AIDS Treatment Activists Coalition (ATAC) said in a flyer they are distributing about the price increase (see Web site www.atac-usa.org/Abbott%20Vulture.pdf).

ATAC, in a letter to Abbott dated Dec. 22, noted that tipranavir, a promising PI under development by Boehringer Ingelheim, uses 400 mg of Norvir daily. If the price increase stands and if tipranavir is approved by the FDA, its price would be about $20,000 a year, several times that of other currently available PIs.

'Abbott has changed the landscape of HIV/AIDS for the worse—is this what it wants to be known for?' asked ATAC. 'We believe that it is in the overall interests of your company to reconsider this shameful and destructive path.'

The HIV Medicine Association called on Abbott to rescind the price increase. 'It is critical that the implications of your actions on access to the majority of treatment regimens available to persons living with HIV/AIDS in the U.S. be given paramount consideration,' it wrote in a Dec. 18 letter to Abbott.

'This increase comes at a time when public programs that provide access to HIV treatment are struggling to keep costs down, and numerous ADAPs have been forced to impose eligibility and formulary restrictions and/or waiting lists.'

Howard Grossman, a physician in New York City with a large HIV practice, said in an e-mail he is 'going to refuse to have Abbott reps in my office and will try to find alternatives to any of their drugs I can.' He is asking the American Academy of HIV Medicine, where he serves as chair of the policy committee, to return funding from Abbott.

'To receive academic or financial support from Abbot Laboratories would be an insult to the many patients who this decision so greatly impacts,' Benjamin Young wrote to the company. The HIV doc and clinical instructor of medicine at the University of Colorado has rescinded any offer to lecture on behalf of the company, attend its advisory committee meetings, or support its research projects.

The London-based AIDSmap quoted one pharmaceutical company research scientist as saying, 'This isn't just an attack on competitors' pricing, it's an attack on their research strategies. Why bother investing in these areas if Abbott has effectively priced you out of the market?'

There is an unconfirmed report that the crusading New York Attorney General, Elliot Spitzer, has initiated an investigation into the price increase.

Grapefruit juice and a number of other drugs have an effect similar to Norvir in terms of slowing the liver's clearance of drugs such a PIs. But none of the alternatives have been studied and so there is no data on whether or how they might be substituted. Given Abbott's price increase, that is an area that researchers are likely to give new attention.


facebook twitter del.icio.us stumble upon digg google +1 reddit email




Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.


  ARTICLES YOU MIGHT LIKE

HIV-criminalization panel Feb. 15 2018-02-14
WORLD NEWS Costa Rica election, PrEP news, HIV outbreak 2018-02-13
Planned Parenthood airs HIV prevention videos on National Black HIV/AIDS Awareness Day 2018-02-08
Planned Parenthood launches youth-led campaign about Bbirth control, sexual health 2018-02-08
Emanuel announces 'Getting to Zero' investments 2018-02-07
SSHC to provide 'Panther' tickets with HIV testing 2018-02-06
Publix decides to add PrEP coverage for employees, HRC responds 2018-02-06
HUD assists HIV/AIDS groups with $4.1M 2018-01-30
AFC calls for state HIV spending transparency 2018-01-29
Howard Brown's Center for Education, Research and Advocacy lists priorities for 2018 2018-01-26
Global Fund and Partners Launch HIV Epidemic Response 2018-01-26
Chicago groups among Elton John grant recipients 2018-01-24
PASSAGES Mathilde Krim, pioneer in fight against HIV/AIDS, dies at 91 2018-01-16
500,000+ LGBTs on Medicaid face uncertainty due to HHS guidance on work requirements 2018-01-12
Committee advances blood-ban resolution to city council 2018-01-12
TPAN CEO Capouch steps down 2018-01-10
Health officials launch 'Getting to Zero' fact-finding tour 2018-01-10
TPAN CEO Capouch stepping down 2018-01-02
Trump fires remaining HIV/AIDS Council members 2017-12-29
FCAN executive director leaving 2017-12-27
Planting Hope event highlights HIV cure research 2017-12-20
'Getting to Zero' town halls Dec. 13, 16 2017-12-20
MOVIES In good 'Shape': Richard Jenkins on his latest film 2017-12-06
National roundup: Texas race, another trans murder, World AIDS Day events 2017-12-05
DIFFA marks World AIDS Day with fest 2017-12-05
CDPH: New HIV cases in "monumental decline" but disparities remain 2017-12-04
Santa Speedo Run zips through Boystown, thousands raised for Center on Halsted 2017-12-04
AFC unveils its 16th annual World of Chocolate 2017-12-03
HRC Marks World AIDS Day On Its 30th Anniversary 2017-12-01
Trans people of color speak out for World AIDS Day, TLC releases three powerful videos 2017-11-30
For World AIDS Day, Illinois HIV Care Connect introduces new content, quiz 2017-11-29
World AIDS Day events in Chicagoland 2017-11-29
World AIDS Day street fest Nov. 30 2017-11-29
STRUT: The 9th Annual World AIDS Day Fashion Show Nov. 26 2017-11-25
Aldermen sponsor resolution calling for end to gay blood-ban 2017-11-22
Dr. Tom Klein talks upcoming award, HIV/AIDS work 2017-11-22
World AIDS Day street fest Nov. 30 2017-11-20
Jussie Smollett's film, 90 DAYS commemorates World AIDS Day with Harle event 2017-11-18
'Sound of Music,' AIDS movie at Music Box Theatre 2017-11-18
New HIV reporting scholarship launches 2017-11-15
 



Copyright © 2018 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 

TRENDINGBREAKINGPHOTOS

Sponsor
Sponsor
Sponsor


 



Sponsor

About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Submit an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group produces Windy City Queercast, & publishes Windy City Times,
The Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community,
Nightspots, Out! Resource Guide, and Identity.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.